Pharming Statistics
Share Statistics
Pharming has 68.03M
shares outstanding. The number of shares has increased by 0.73%
in one year.
| Shares Outstanding | 68.03M |
| Shares Change (YoY) | 0.73% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.01% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 141 |
| FTD / Avg. Volume | 2.73% |
Short Selling Information
The latest short interest is 1.62K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 1.62K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -62.96 and the forward
PE ratio is -105.2.
Pharming's PEG ratio is
-10.14.
| PE Ratio | -62.96 |
| Forward PE | -105.2 |
| PS Ratio | 2.26 |
| Forward PS | 1.8 |
| PB Ratio | 3.13 |
| P/FCF Ratio | -258.67 |
| PEG Ratio | -10.14 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Pharming.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91,
with a Debt / Equity ratio of 0.51.
| Current Ratio | 3.91 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 15.08 |
| Debt / FCF | -41.84 |
| Interest Coverage | -0.95 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $735,643.56 |
| Profits Per Employee | $-26,347.43 |
| Employee Count | 404 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 0.66 |
Taxes
| Income Tax | 2.43M |
| Effective Tax Rate | -29.53% |
Stock Price Statistics
The stock price has increased by 11.82% in the
last 52 weeks. The beta is 0.44, so Pharming's
price volatility has been higher than the market average.
| Beta | 0.44 |
| 52-Week Price Change | 11.82% |
| 50-Day Moving Average | 8.81 |
| 200-Day Moving Average | 8.56 |
| Relative Strength Index (RSI) | 65.58 |
| Average Volume (20 Days) | 5,168 |
Income Statement
In the last 12 months, Pharming had revenue of 297.2M
and earned -10.64M
in profits. Earnings per share was -0.15.
| Revenue | 297.2M |
| Gross Profit | 252.72M |
| Operating Income | -8.32M |
| Net Income | -10.64M |
| EBITDA | 7.19M |
| EBIT | 245K |
| Earnings Per Share (EPS) | -0.15 |
Full Income StatementBalance Sheet
The company has 53.04M in cash and 108.42M in
debt, giving a net cash position of -55.38M.
| Cash & Cash Equivalents | 53.04M |
| Total Debt | 108.42M |
| Net Cash | -55.38M |
| Retained Earnings | -265.36M |
| Total Assets | 403.18M |
| Working Capital | 136.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -1.79M
and capital expenditures -796K, giving a free cash flow of -2.59M.
| Operating Cash Flow | -1.79M |
| Capital Expenditures | -796K |
| Free Cash Flow | -2.59M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 85.03%, with operating and profit margins of -2.8% and -3.58%.
| Gross Margin | 85.03% |
| Operating Margin | -2.8% |
| Pretax Margin | -2.77% |
| Profit Margin | -3.58% |
| EBITDA Margin | 2.42% |
| EBIT Margin | -2.8% |
| FCF Margin | -0.87% |
